Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

Recruiting now · Phase 2

Conditions studied: Anemia

In brief

This is an open-label, single institution study evaluating the efficacy of intravenous iron sucrose monotherapy in patients with thoracic, breast, GU and GI malignancies undergoing neoadjuvant chemotherapy with the goal of undergoing surgical resection.

Key facts

Study ID
NCT05800600
Run by
Fox Chase Cancer Center
People needed
34
Starts
2023-03-15
Expected to finish
2028-02-01
Last updated by the study team
2026-05-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.